Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Broncho-Vaxom in Reducing Recurrence in Children With Steroid-sensitive Nephrotic Syndrome: Prospective, Randomized Controlled, Multicenter Clinical Study

NCT05044169 is registered in ClinicalTrials.gov with Fang Deng as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05044169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Broncho-Vaxom in Reducing Recurrence in Children With Steroid-sensitive Nephrotic Syndrome: Prospective, Randomized Controlled, Multicenter Clinical Study
Lead sponsor
Fang Deng
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2021
Completion date
December 31, 2023
Enrollment
83 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotic syndrome in children